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Skin Damage by UV A: A Broad-Spectrum Event 
Using an cxperimental human model for chronic skin damage, 
Lavker el (I I (p. 17) ha vc found ev idence that thc action spectrum 
for UV A-indu ced chro ni c cpidermal and derm al damagc extends 
into longer UV wavelcngths. C urrent conccpts about long-tcrm 
actinic damage are derived pJ'imaril y /Tom experimental studi es of 
the UYE portion of the ultra vio let spectrum. It is more diffi cult to 
assess dam<lge from UV A at usual exposure leve ls. because it 
doesn't ca use immediate, obvious damagc such as a sunburn unl ess 
it is admini stered with a photoscnsitizer, such as psoralen. but 
recent cvidence from an imal and human studies suggests that UV A 
may also con tribute signifi cantly to photodamage. Sincc photodam-
aged skin is the resu lt of cumula tive solar exposure, both chronic 
and subacute, the in vestigators dcveloped a human model for 
cumulative dam<lge by using repetitive exposures to suberytherm<l l 
doses of UV A over rclatively short durations. Subjccts wcre 
irradiated with five different UVA wavelcngths o nce daily for 9 
days and biopsied, and biopsies wcre ana lyzed for epidermal and 
dermal changes. C hronic epidcrm al changes were indu ccd morc 
e ffici ently by thc shorter UVA wavclengths (335-345 nm). but thc 
spectrum for chronic derm al photodam age was fl at and broad, 
extending from 335 to 400 nm. These fi ndings stro ngl y suggest that 
the action spectrum for chronic photodamagc differs fi'oJl1 the 
spcctrum for acute erythema and includes UV A wavelengths . In order 
to prevent chronic photodamage, therefore, sunscreens that filtcr a 
broad spectrum of UVA cxtending out to 400 nl11 and that filter 
effectively must be developed . T his c:\:p eril11cnra l model may be lIsefi.tl 
in developing a m easure of sun protection for UV A sunscreens similar 
to thc sun protection factor, or SPF. lIsed fo r UVB sunscrecns . 
Chromosome Abnormalities in CTCL: A New and Better Method of Detection 
Karenko 1'1 (II (p . 22) show that chrom osoma ll y abnormal lympho-
cytes found in the blood of cutancous T-cell lymphoma (CTCL) 
patients also can be detected in the blood of patients with para-
psoriasis en plaque. both by conventional chromosome ana lys is and 
also by ill .IiI" hybridization of blood lymphocytes in interphasc. 
Patients in the later stages of CTCL have a wide spectrum of 
chromosoma l abnormalities . The drawback of conventional cyto-
genetics ha s been thc need to culture the cells, a process in which 
the malignant ce lls arc often lost. To look for chromosoma.l changes 
early in th e course of CTCL, and as a possible diagnostic aid, the 
inves tigators compared these methods in con vcntional chromo-
some analys is and two different mcthods of intcrphasc ill sirll 
hybridization, o n periphe ral blood lymphocytes. All three meth ods 
were in agrecm ent, and findings with thc ill .1';111 method w cre 
reprodu cible at intervals of several m onths. T he level of abnormal-
ities differed in CTCL. parapsoriasis c n plaque , and contro ls , and 
the development of clones of cells with chromosomal abnormali ties 
was usually found to precede relapse or progrcssion of disease, 
suggesting that chromoso mal ill siTJI hybridization methods may be 
uscful in diagnosis and followup. Further studies wi ll be needed to 
better defin e thc chromosomal regions affected in CTCL and to 
determine whe thcr chromosomal abcrrations in CTCL may refle ct 
genetic instability. The abcrrations found in parapsoriasis en plaque 
by the ill S;III m ethod support the view th at a subgroup of 
large-plaque parapsori asis is an ea rl y stage o f CTCL. T he Il ew 
mcth od may replace thc much more labor-inrcnsive traditional 
cytogenetic m e thods and may facilitate studies of chromosom al 
abnormalities in CTCL and its clinica l precursors. 
Complementation Studies in Type II Albinism: A Way to Approach P gene Function 
T he human P gene, w hi ch encodes a m elallosoma l membran e 
protein of unknown fun ction. is one of thrcc gcnes mutatcd in the 
th ree known typcs of human albinism. Mutations in the P gcne 
produce type If ocu locutaneous albini sm (OCA2) in humallS. and 
mutations in the homologous p-locus in mi ce cause pink-cyed 
dilution . In order to begin to discern the ftlnction of thc P gene, 
SviderskaYil el al (p . 30) have produced mouse m elanocytc and 
m elanoblast cell lin es fi'om mi ce that w erc compound hete rozy-
gotes for mutations in the p locus. la cking a functional p gene and 
h en ce bypopigmented , a p-null mutant ceU line. To develop an 
assay for human P gene fun ction. thc in vestigators reintroduced a 
normal human P gene into thc p-null cell s and examined the 
pigmentation in the transfected cells. Reintroductioll of a fUll c-
tional P gene complemented the jJ-nullmutations and rcsrored both 
melanin biosynthesis and visibl c pigmentation in the p-null mutant 
cells. indi cating that the transfected human P gene was fun ctional 
and also that the human and mo use gcncs are fu nctionall y equiv-
alent. In experiments to dcte rmin e to w hat extent P genes from 
patients with OCA2 could also rcstore pigm cntation to the p-null 
mu tants. tra nsfection with each of rwo OCA2 mutan t human P 
cDNAs resulted in o nl y partial complementati on , producing pig-
m entation that correspo nd ed closely with the clini cal phenotypes 
associated with these mutations. The res ults indicatc that the e ffcct 
of the J11utant genes can be assessed even without a direct functional 
assay for thc protein coded by thc P gene. T hc complementation 
assay can be used to di stinguish true OCA2 nll~tati on s from 
non pathologic polymorphi sJ11s. to quantitatc the effects of these 
mutations on P fimction, and to begin to de termin e ill lI;tro what 
types of processes are controllcd by the P genc. These findin gs will 
help to detcrmine the function of thc P gcnc. 
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A Better Way to Diagnose EBA 
C hen 1'1 " I (p. 68) have developed an ELI SA for rapid de tec tion of 
an ti-type VII coll agen autoantibodies in serum , a test that m ay be 
very usefu l in the diagnosis of epidermolys is bull osa acqui sita 
(EBA). EBA, an au toimmune blisterin g sk.in disease character ized 
by IgG autoantibod ies to type VII co lla gen. a majo r co mpo nent of 
<t11 cho rin g fibri ls, ca ll be difficu lt to distinguish from othe r bliste rin g 
diseases. particularly pemphigoid . o n clin ical grounds. T he au tho rs' 
previous stud ies had shown that a ll autoa lltibod ies to type VII 
coll agen in th e sera of EBA patients as we ll as of patients with 
bu ll o us systemi c lupus e rythem atosus (BSLE) . w hi ch arc also 
known to react w ith type VII co ll agen, recogni zed four major 
epitopes localized within the am in o-termina l Il oncol\ agenous do-
main, or NCl . Sera fi'om patie nts w ith EBA and BSLE reacted with 
th t; rt;combin ant NC 1 protein in ELI SA. but sera fi'om 16 patients 
w ith pelllphigoid , 11 patients w ith pClIlphigus. and a battery of 
con tro ls did not re:l ct. T he ELISA appea rs to be mo re sensitive than 
either indirect illlmun oA uo rescence o r imlllutl o biotting in detec t_ 
in g EBA se ra w ith low tite rs of autoantibodies. Sin ce the target 
antigen is full y post- tran slationa ll y m od ifi ed and not denatured, it 
may recogn ize autoa ntibodies tha t bind o nl y to confo rma tio n al 
ep itopes and not to denatured antigens . for example in an ill1t11u_ 
nob lor. Because of the con venience and widespread ava ilabili ty of 
the ELISA techno logy, the new assay ca n be used w idely fo l' 
screening sera fi'olll patients w ith E13A o r I3SLE and for fo ll owi ng 
antibody titers to dete rmin e whether an tibody levels corre late with 
disease acti vity. 
Why is Borrelial Lymphocytoma So Rare in North America? 
Pi c ken el " I (p . 92) show that borre li al lym phocytom a iJl Eu ropean 
pa tients ca n be ca used by at least two genom ic gro ups of Borrcli(/ 
{J/ ,,:~dOljeri sens u lato, one of w hi ch is also presen t in North Am eri ca. 
T he vast m ajori ty of cases of soli tary lymp hocytoma occu r in 
Europe, and reports from North America are very unusual. T his 
observation, coupled w ith the presence of three borrelial species 
iso lated from patients in Europe (B. blllgdOljeri sellSu stricto. B. 
g(/rillii. and B. (/Jz elii) , but onl y one human path ogenic species in 
North Am e rica (8. IJllrgdOljcri sens Ll stricto), has promoted specula-
tio n that the specifi c cl inica l manifestatio ns of Lym e borre liosis may 
be co rre lated w ith specific species of borre lia. T his led the inves-
tigatOl-s to ask whether lymph ocytom a iso lates of borre li" derived 
fi'ol11 Slovene patien ts all belong to the species B. (IJz ci ii andlor B. 
.!?"rillii. C haracte rization of five iso lates obta in ed over the course of 
several years showed that four were 8. (IJzclii , but the mo leculat· 
characte ri sti cs of the fifth iso latt; were most simil ar to those of a ral'e 
ge nomic gro up, the ON 127-gro up of borrelia, w hich is closely 
related to the common North Am eri ca n spec il:s, B. IJ/lrgdor/i'ri sensu 
stricto, and also is fo und in N o rth Am e ri ca. If these two species, B. 
(I/"zcli i and the fifth isolate, represenr the on ly etio logic agents of 
borrelial lymphocytom a, the pau city of North Al11erican cases of 
lymphocytoma could be exp lain ed by the sca rcity of ON127- group 
iso lates. Another in te rpretation of the data, however, is that the 
specifi c species of borre li a and the cl inical manifestations of LYllle 
disease arc not well correlated. so tha t o ne species m ay ca use Iltore 
than o ne clinica l conditio n , as has already been shown fo r both 
eryth em a migran s and ne uro bo n·e li os is. In thi s case, rl:asollS fo r the 
predominance of soli tary lymphocytoma in Euro pe remain to be 
e lu cidated. 
Inhibition of S6 Kinase By Rapamycil1: A Potential Role in Treatment of Psoriasis? 
Man y ce llul ar signali ng pathways criti ca l to cellul ar regul ation are 
in tu rn regul ated b y kinases, wh ich phosphorylate substrates, for 
exam ple, changing inactive substrate protein s inro active enzym es . 
and kin ase function is o fte n a rate-limiting step. S6 ki nase is a 
parti cipant in a sel·ies of proteul kjn ase rea ction s, o r a protein kinase 
cascade. and regul ates trans lation o r speciti c ml~NAs. S6 kin ase 
;lctivity is itself regulated by phosphorylatio n . w hi ch typicaUy 
occurs in respo nse to growth facto rs. It was recentl y discove red that 
activation of S6 ki nase by growth f.1cto rs is inh ibited by the 
il1l munos uppressive d ru g rapamycin , whi ch ca n be used to treat 
pso l'ia sis, suggestin g that S6 kinase may be in volved in the patho-
genesis of pso ri asis. In this iss lle, C ho i cf (/1 (p . 98) show. in 
agreem ent with this hypothesis. that S6 kinase enzym atic activity is 
higher in psoriatic les io ns than in non-Iesional o r no rm al epi dermis. 
S6 kinase ml~NA and protein levels were not el evated , indicating 
that the observed increase in S6 kinase activity rose from activation 
o f S6 kin ase r:lther than from an increase in expressio n. i. e .. in th e 
am o unts of S6 kinase mKN A o r enzym e. T he growth filctors EGF 
and TGF-Cl', w hi ch h ave been impli cated in studi es of psori as is, 
st imul ated 56 k in ase activity in cultured hum an ke ratinocytes. 
Kapamycin inhibi ted TGF-LY-stilllul ated S6 k.i nase activ ity and al so 
inhibi ted ke ratinocyte growth. T he au thors propose the following 
scenario in the pathogenesis of psoriasi s: EGF receptor ligands such 
as TGF-cy o r arnphiregu lin , w hich arc known to be elevated in 
les io ns of pso ri as is. stimul ate the EGF receptor, w hi ch increases S6 
kinase activity, w hi ch is in turn a li nk in the c hain of even ts lead in g 
to epidermal hype rplasia characte ristic of pso riasi s. Rapamycin ma y 
be bene fi cial in psoriasis by virtue of its ab ility to interrupt thi s 
pathway. 
